Cargando…
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). The activation of inflammatory cells is crucial for the development of MS and is shown to induce intracellular glycolytic metabolism in pro-inflammatory microglia and macrophages, as well as CNS-resident astrocyt...
Autores principales: | Wetzels, Suzan, Wouters, Kristiaan, Schalkwijk, Casper G., Vanmierlo, Tim, Hendriks, Jerome J. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343955/ https://www.ncbi.nlm.nih.gov/pubmed/28212304 http://dx.doi.org/10.3390/ijms18020421 |
Ejemplares similares
-
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
por: Wetzels, Suzan, et al.
Publicado: (2019) -
Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression
por: Wetzels, Suzan, et al.
Publicado: (2018) -
Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification
por: van Eupen, Marcelle GA, et al.
Publicado: (2013) -
Scopoletin Protects against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation
por: Chang, Wen-Chang, et al.
Publicado: (2015) -
An advanced glycation endproduct (AGE)‐rich diet promotes accumulation of AGEs in Achilles tendon
por: Skovgaard, Dorthe, et al.
Publicado: (2017)